We are live on
!
Find out more
Artisan Partners Portfolio holdings
AUM
$61.3B
1-Year Est. Return
26.25%
This Fund
S&P 500
This Quarter
Est. Return
-2.12%
1 Year Est. Return
+26.25%
3 Year Est. Return
+105.27%
5 Year Est. Return
+134.81%
10 Year Est. Return
+672.1%
AUM
$61.3B
AUM Growth
-$4.07B
(-6.2%)
Cap. Flow
-$917M
Cap. Flow
% of AUM
-1.5%
Top 10 Holdings %
Top 10 Hldgs %
25.01%
Holding
365
New
37
Increased
119
Reduced
167
Closed
35
Top Buys
| 1 |
Coupang
CPNG
|
+$659M |
| 2 |
Axalta
AXTA
|
+$515M |
| 3 |
JPMorgan Chase
JPM
|
+$355M |
| 4 |
Edwards Lifesciences
EW
|
+$333M |
| 5 |
IQVIA
IQV
|
+$329M |
Top Sells
| 1 |
Suncor Energy
SU
|
+$860M |
| 2 |
Lam Research
LRCX
|
+$653M |
| 3 |
PayPal
PYPL
|
+$439M |
| 4 |
Netflix
NFLX
|
+$365M |
| 5 |
Danaher
DHR
|
+$317M |
Sector Composition
| 1 | Financials | 26.49% |
| 2 | Healthcare | 18.86% |
| 3 | Technology | 17.27% |
| 4 | Industrials | 10.97% |
| 5 | Communication Services | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Akamai
AKAM
$18.3B
| $20.4M | 0.03% |
+177,406
| New | +$17.8M |
|
277
Constellation Brands
STZ
$22.4B
| $20.2M | 0.03% |
134,506
-16,133
| -11% | -$2.49M |
|
|
HSAI
278
Hesai Group
HSAI
$2.45B
| $19.7M | 0.03% |
1,031,044
+184,818
| +22% | +$4.66M |
|
279
Expeditors International
EXPD
$23.3B
| $19.4M | 0.03% |
135,133
-9,329
| -6% | -$1.42M |
|
280
Zegna
ZGN
$3.49B
| $19.2M | 0.03% |
1,840,151
-90,197
| -5% | -$932K |
|
281
BridgeBio Pharma
BBIO
$16.5B
| $18.9M | 0.03% |
254,392
-24,675
| -9% | -$1.79M |
|
282
Luxfer Holdings
LXFR
$462M
| $18.3M | 0.03% |
1,504,665
-195,885
| -12% | -$2.73M |
|
283
Freshpet
FRPT
$2.67B
| $17.6M | 0.03% |
+298,914
| New | +$21M |
|
284
MGM Resorts International
MGM
$11.9B
| $17.5M | 0.03% |
472,188
-53,699
| -10% | -$1.91M |
|
285
Vaxcyte
PCVX
$8.12B
| $17.3M | 0.03% |
297,432
-6,617
| -2% | -$359K |
|
286
Agios Pharmaceuticals
AGIO
$2.37B
| $16.3M | 0.03% |
481,516
-22,969
| -5% | -$651K |
|
|
YSS
287
York Space Systems
YSS
$2.79B
| $15.6M | 0.03% |
+705,746
| New | +$17.1M |
|
288
Masco
MAS
$15.7B
| $14.8M | 0.02% |
+245,251
| New | +$16.6M |
|
289
T-Mobile US
TMUS
$203B
| $14.3M | 0.02% |
+68,323
| New | +$14M |
|
290
RxSight
RXST
$204M
| $12.7M | 0.02% |
2,058,684
-98,580
| -5% | -$819K |
|
291
Dyne Therapeutics
DYN
$3.93B
| $11.2M | 0.02% |
619,457
-30,234
| -5% | -$521K |
|
|
ARIS
292
Aris Mining
ARIS
$3B
| $10.9M | 0.02% |
584,370
+88,130
| +18% | +$1.67M |
|
|
LINE
293
Lineage Inc
LINE
$10B
| $10.8M | 0.02% |
329,491
+34,571
| +12% | +$1.28M |
|
294
Globant
GLOB
$1.34B
| $10.4M | 0.02% |
225,877
+18,967
| +9% | +$1.05M |
|
295
Stoke Therapeutics
STOK
$1.81B
| $10.3M | 0.02% |
+315,492
| New | +$10.3M |
|
296
Amdocs
DOX
$5.52B
| $9.16M | 0.01% |
140,326
-10,854
| -7% | -$794K |
|
|
VG
297
Venture Global Inc
VG
$32.9B
| $8.03M | 0.01% |
+509,534
| New | +$5.46M |
|
298
iShares MSCI India ETF
INDA
$6.81B
| $7.86M | 0.01% |
167,700
+42,246
| +34% | +$2.16M |
|
299
Ocular Therapeutix
OCUL
$2.12B
| $7.65M | 0.01% |
902,931
-160,440
| -15% | -$1.53M |
|
300
Moelis & Co
MC
$4.98B
| $7.32M | 0.01% |
128,399
-215,598
| -63% | -$14M |
|
Similar funds
